How much is the Leuprolide Acetate Market market?

The leuprolide acetate market market size is estimated to grow at $$ 1433.5 mn in 2023. Read More

What is the growth rate of the Leuprolide Acetate Market market?

The growth rate of the leuprolide acetate market year-over-year is 9.7%. Read More

Which region held the largest market share in the Leuprolide Acetate Market market?

North America is the region to held the largest market share with 45% growth. Read More

Who are the key players in the Leuprolide Acetate Market market?

AbbVie Inc., Aspen Oss B.V., Astellas Pharma Inc., Bachem AG, Beijing Biote Pharmaceutical Co. Ltd, Livzon Pharmaceutical Group Inc., Merck KGaA, Midas Pharma GmbH, .... Read More

Which Segment has the largest market share in the Leuprolide Acetate Market market?

End-user is the segment that has the largest market share in the market. Read More

Leuprolide Acetate Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, China, Germany, Canada - Size and Forecast 2024-2028

Published: Oct 2024
Pages: 133
SKU: IRTNTR71763

Enjoy complimentary customisation on priority with our Enterprise License!

Leuprolide Acetate Market Size 2024-2028

The leuprolide acetate market size is forecast to increase by USD 1.43 billion at a CAGR of 9.7% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of advanced prostate cancer and the increasing popularity of long-acting suspension formulations, such as Eligard and Lupron Depot. These formulations offer convenience and effectiveness for patients undergoing hormone therapy. Additionally, the preference for minimally invasive treatments for conditions like endometriosis, anemia, and uterine fibroids is driving the demand for Leuprolide Acetate as an alternative to surgery. The use of advanced drug delivery systems, such as Camcevi, further enhances the market's potential. Intramuscular injections remain a common administration route for Leuprolide Acetate, ensuring patient compliance and convenience. Overall, the market's growth is attributed to these factors, making it an attractive investment opportunity for industry players.

What will be the Size of the Market During the Forecast Period?

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

2.2 Market characteristics
- Market characteristics analysis

2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition

3.2 Market segment analysis
- Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Leuprolide Acetate Market 2018 - 2022
- Historic Market Size - Data Table on Global Leuprolide Acetate Market 2018 - 2022 ($ million)

4.2 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)

4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)

4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028

5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)

6.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user

6.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)

6.4 Clinics - Market size and forecast 2023-2028
- Chart on Clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Clinics - Year-over-year growth 2023-2028 (%)

6.5 Research and academic institiutions - Market size and forecast 2023-2028
- Chart on Research and academic institiutions - Market size and forecast 2023-2028 ($ million)
- Data Table on Research and academic institiutions - Market size and forecast 2023-2028 ($ million)
- Chart on Research and academic institiutions - Year-over-year growth 2023-2028 (%)
- Data Table on Research and academic institiutions - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)

8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison

8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)

8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)

8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)

8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)

8.8 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)

8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)

8.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)

8.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)

8.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers

9.2 Market challenges

9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview

10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

10.3 Landscape disruption
- Overview on factors of disruption

10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered

11.2 Market positioning of companies
- Matrix on companies position and classification

11.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings

11.4 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings

11.5 Bachem AG
- Bachem AG - Overview
- Bachem AG - Business segments
- Bachem AG - Key offerings
- Bachem AG - Segment focus

11.6 Beijing Biote Pharmaceutical Co. Ltd
- Beijing Biote Pharmaceutical Co. Ltd - Overview
- Beijing Biote Pharmaceutical Co. Ltd - Product / Service
- Beijing Biote Pharmaceutical Co. Ltd - Key offerings

11.7 Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. - Overview
- Livzon Pharmaceutical Group Inc. - Product / Service
- Livzon Pharmaceutical Group Inc. - Key offerings

11.8 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus

11.9 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings

11.10 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings

11.11 Tolmar Pharmaceuticals Inc.
- Tolmar Pharmaceuticals Inc. - Overview
- Tolmar Pharmaceuticals Inc. - Product / Service
- Tolmar Pharmaceuticals Inc. - Key offerings